Total Payments
$60,297
2024 Payments
$4,893
Companies
47
Transactions
1,514
Medicare Patients
17,910
Medicare Billing
$16.9M
Payment Breakdown by Category
Other$30,542 (50.7%)
Food & Beverage$21,670 (35.9%)
Travel$3,898 (6.5%)
Consulting$3,816 (6.3%)
Education$371.08 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,342 | 16 | 48.7% |
| Food and Beverage | $21,670 | 1,470 | 35.9% |
| Travel and Lodging | $3,898 | 16 | 6.5% |
| Consulting Fee | $3,816 | 2 | 6.3% |
| Honoraria | $1,200 | 1 | 2.0% |
| Education | $371.08 | 8 | 0.6% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$60,297
1,513 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $18,322 | 140 | $0 (2024) |
| Amgen Inc. | $14,587 | 191 | $0 (2024) |
| PFIZER INC. | $9,372 | 228 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,684 | 114 | $0 (2024) |
| Janssen Biotech, Inc. | $2,592 | 220 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $2,243 | 3 | $0 (2017) |
| Horizon Therapeutics plc | $2,039 | 77 | $0 (2023) |
| ABBVIE INC. | $1,391 | 75 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,248 | 82 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $850.53 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,893 | 190 | Amgen Inc. ($1,916) |
| 2023 | $3,916 | 177 | Novartis Pharmaceuticals Corporation ($1,164) |
| 2022 | $2,635 | 170 | Janssen Biotech, Inc. ($436.92) |
| 2021 | $2,510 | 186 | Janssen Biotech, Inc. ($419.28) |
| 2020 | $3,780 | 156 | Horizon Therapeutics plc ($1,428) |
| 2019 | $12,180 | 173 | Amgen Inc. ($10,466) |
| 2018 | $4,639 | 189 | UCB, Inc. ($2,876) |
| 2017 | $25,744 | 273 | UCB, Inc. ($14,195) |
All Payment Transactions
1,514 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: INFLIXIMAB | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 11/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,812 | 134,991 | $4.5M | $1.5M |
| 2022 | 37 | 4,533 | 509,776 | $15.6M | $5.7M |
| 2021 | 39 | 5,168 | 320,327 | $12.3M | $5.1M |
| 2020 | 39 | 4,397 | 246,482 | $9.6M | $4.5M |
Total Patients
17,910
Total Services
1,211,576
Medicare Billing
$16.9M
Procedure Codes
144
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 112 | 20,950 | $1.7M | $700,752 | 41.8% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 60 | 62,400 | $748,800 | $244,023 | 32.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 35 | 13,600 | $945,000 | $142,578 | 15.1% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 23 | 23,120 | $230,800 | $108,359 | 46.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 37 | 2,580 | $77,400 | $47,637 | 61.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 556 | $108,976 | $47,298 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 394 | 394 | $119,382 | $43,538 | 36.5% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 11 | 4,410 | $56,713 | $34,643 | 61.1% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 233 | 1,982 | $69,370 | $34,571 | 49.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 15 | 1,527 | $238,212 | $34,187 | 14.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 99 | 156 | $42,588 | $14,484 | 34.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 144 | 307 | $40,971 | $14,161 | 34.6% |
| 86481 | Tuberculosis test, enumeration of t-cells | Office | 2023 | 129 | 129 | $16,125 | $12,453 | 77.2% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 109 | 109 | $19,075 | $6,566 | 34.4% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 272 | 526 | $32,490 | $5,904 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $14,742 | $5,717 | 38.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 191 | 191 | $18,145 | $5,541 | 30.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 123 | 437 | $19,228 | $4,555 | 23.7% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 249 | 250 | $10,000 | $3,149 | 31.5% |
| 86226 | Measurement of dna antibody, single stranded | Office | 2023 | 266 | 267 | $9,345 | $3,147 | 33.7% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 232 | 232 | $8,120 | $3,099 | 38.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 44 | 129 | $8,385 | $2,673 | 31.9% |
| 86038 | Screening test for autoimmune disorder | Office | 2023 | 204 | 205 | $7,175 | $2,419 | 33.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 35 | 44 | $20,295 | $1,937 | 9.5% |
| 86431 | Rheumatoid factor level | Office | 2023 | 250 | 254 | $5,080 | $1,397 | 27.5% |
About Dr. Timothy Lonesky, D.O
Dr. Timothy Lonesky, D.O is a Internal Medicine healthcare provider based in Somerset, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447478029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Lonesky, D.O has received a total of $60,297 in payments from pharmaceutical and medical device companies, with $4,893 received in 2024. These payments were reported across 1,514 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,342).
As a Medicare-enrolled provider, Lonesky has provided services to 17,910 Medicare beneficiaries, totaling 1,211,576 services with total Medicare billing of $16.9M. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Somerset, KY
- Active Since 04/21/2007
- Last Updated 10/29/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447478029
Products in Payments
- Cimzia (Drug) $18,269
- INFLECTRA (Biological) $7,349
- Prolia (Biological) $6,656
- EVENITY (Biological) $4,810
- KRYSTEXXA (Biological) $3,172
- Uloric (Drug) $2,243
- XELJANZ (Drug) $1,659
- Enbrel (Biological) $1,396
- TREMFYA (Drug) $1,171
- ORENCIA (Biological) $1,117
- COSENTYX (Biological) $1,044
- SAPHNELO (Biological) $828.11
- BENLYSTA (Biological) $781.00
- COSENTYX (Drug) $768.67
- SIMPONI ARIA (Biological) $734.32
- RINVOQ (Biological) $667.91
- TALTZ (Drug) $597.79
- REMICADE (Biological) $572.45
- ACTHAR (Biological) $489.13
- Rituxan (Biological) $345.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Somerset
Homer Nelson, Md, MD
Internal Medicine — Payments: $38,225
Internal Medicine $38,225
Jae Hong, Md, MD
Internal Medicine — Payments: $18,094
Internal Medicine $18,094
Dr. Deepak Jain, Md, MD
Internal Medicine — Payments: $14,061
Internal Medicine $14,061
Mohammad Afzal, Md, MD
Internal Medicine — Payments: $12,500
Internal Medicine $12,500
Dr. Tariq Rizvi, Md, MD
Internal Medicine — Payments: $11,662
Internal Medicine $11,662
Dr. Pravien Khanna, Md Mph, MD MPH
Internal Medicine — Payments: $11,566
Internal Medicine $11,566